Pluristem Therapeutics Inc (PSTI)

[Auto1]

And think about it... Truth be told,
This indication, at the time of trial design was PSTI's highest opportunity of success. Higher than any other possible indications based on the MOA (mechanism of action) - mesenchymal stem cell activity, healing and regenerating - the 'promise' of stem cell treatment. CLI has the Highest chance of success for this MOA to demonstrate its most statistically significant effects. Literally, angiogenesis and vasculogenesis … growing new tissue, vessels, capillaries, in essence, re-birthing tissues, vasculature and limbs.


Now, re-read the primary investigators quotes, do you get the sense that this type of success is taking place in the trial????


And now... Study Changes and reaffirmation of 2020 as end of study. Think about it, read it for yourself.